|
US4187852A
(en)
|
1976-07-09 |
1980-02-12 |
The University Of Alabama |
Synthetic elastomeric insoluble cross-linked polypentapeptide
|
|
US4132746A
(en)
|
1976-07-09 |
1979-01-02 |
University Of Alabama, Birmingham Medical & Education Foundation |
Synthetic elastomeric insoluble cross-linked polypentapeptide
|
|
DE2923787A1
(de)
*
|
1979-06-12 |
1980-12-18 |
Max Planck Gesellschaft |
Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel
|
|
US4474851A
(en)
*
|
1981-10-02 |
1984-10-02 |
The University Of Alabama In Birmingham |
Elastomeric composite material comprising a polypeptide
|
|
US4500700A
(en)
|
1981-10-02 |
1985-02-19 |
The Board Of Trustees Of The University Of Alabama For The University Of Alabama In Birmingham |
Elastomeric composite material comprising a polypentapeptide having an amino acid of opposite chirality in position three
|
|
US4589882A
(en)
|
1983-09-19 |
1986-05-20 |
Urry Dan W |
Enzymatically crosslinked bioelastomers
|
|
US4752638A
(en)
|
1983-11-10 |
1988-06-21 |
Genetic Systems Corporation |
Synthesis and use of polymers containing integral binding-pair members
|
|
US4749647A
(en)
|
1984-06-22 |
1988-06-07 |
Genetic Systems Corporation |
Polymerization-induced separation assay using recognition pairs
|
|
US4605641A
(en)
|
1984-10-09 |
1986-08-12 |
Hoffmann-La Roche Inc. |
Synthetic vasoactive intestinal peptide analogs
|
|
US4780409A
(en)
|
1985-05-02 |
1988-10-25 |
Genetic Systems Corporation |
Thermally induced phase separation immunoassay
|
|
US4870055A
(en)
*
|
1986-04-17 |
1989-09-26 |
University Of Alabama At Birmingham |
Segmented polypeptide bioelastomers to modulate elastic modulus
|
|
US4783523A
(en)
*
|
1986-08-27 |
1988-11-08 |
Urry Dan W |
Temperature correlated force and structure development of elastin polytetrapeptides and polypentapeptides
|
|
US5614492A
(en)
|
1986-05-05 |
1997-03-25 |
The General Hospital Corporation |
Insulinotropic hormone GLP-1 (7-36) and uses thereof
|
|
US7138486B2
(en)
*
|
1986-05-05 |
2006-11-21 |
The General Hospital Corporation |
Insulinotropic hormone derivatives and uses thereof
|
|
US4898926A
(en)
*
|
1987-06-15 |
1990-02-06 |
The University Of Alabama At Birmingham/Research Foundation |
Bioelastomer containing tetra/penta-peptide units
|
|
US5830713A
(en)
*
|
1986-11-04 |
1998-11-03 |
Protein Polymer Technologies, Inc. |
Methods for preparing synthetic repetitive DNA
|
|
US5773249A
(en)
*
|
1986-11-04 |
1998-06-30 |
Protein Polymer Technologies, Inc. |
High molecular weight collagen-like protein polymers
|
|
US6184348B1
(en)
*
|
1986-11-04 |
2001-02-06 |
Protein Polymer Technologies |
Functional recombinantly prepared synthetic protein polymer
|
|
US5770697A
(en)
*
|
1986-11-04 |
1998-06-23 |
Protein Polymer Technologies, Inc. |
Peptides comprising repetitive units of amino acids and DNA sequences encoding the same
|
|
US6018030A
(en)
*
|
1986-11-04 |
2000-01-25 |
Protein Polymer Technologies, Inc. |
Peptides comprising repetitive units of amino acids and DNA sequences encoding the same
|
|
US5496712A
(en)
*
|
1990-11-06 |
1996-03-05 |
Protein Polymer |
High molecular weight collagen-like protein polymers
|
|
US5514581A
(en)
*
|
1986-11-04 |
1996-05-07 |
Protein Polymer Technologies, Inc. |
Functional recombinantly prepared synthetic protein polymer
|
|
US5243038A
(en)
*
|
1986-11-04 |
1993-09-07 |
Protein Polymer Technologies, Inc. |
Construction of synthetic DNA and its use in large polypeptide synthesis
|
|
US5641648A
(en)
*
|
1986-11-04 |
1997-06-24 |
Protein Polymer Technologies, Inc. |
Methods for preparing synthetic repetitive DNA
|
|
US5606019A
(en)
*
|
1987-10-29 |
1997-02-25 |
Protien Polymer Technologies, Inc. |
Synthetic protein as implantables
|
|
IL87055A
(en)
|
1988-07-08 |
1994-06-24 |
Illana Gozes |
Conjugates of vasoactive intestinal peptide (vip) and of fragments thereof and pharmaceutical compositions comprising them
|
|
US5137711A
(en)
|
1988-07-19 |
1992-08-11 |
Mallickrodt Medical, Inc. |
Paramagnetic dtpa and edta alkoxyalkylamide complexes as mri agents
|
|
US5766883A
(en)
|
1989-04-29 |
1998-06-16 |
Delta Biotechnology Limited |
Polypeptides
|
|
US5143854A
(en)
|
1989-06-07 |
1992-09-01 |
Affymax Technologies N.V. |
Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
|
|
US5234907A
(en)
|
1989-06-30 |
1993-08-10 |
Hoffmann-La Roche Inc. |
Synthetic vasoactive intestinal peptide analogs
|
|
US5236904A
(en)
|
1989-09-18 |
1993-08-17 |
Senetek, Plc |
Erection-inducing methods and compositions
|
|
US5447912A
(en)
|
1989-09-18 |
1995-09-05 |
Senetek, Plc |
Erection-inducing methods and compositions
|
|
US5545618A
(en)
|
1990-01-24 |
1996-08-13 |
Buckley; Douglas I. |
GLP-1 analogs useful for diabetes treatment
|
|
ATE114458T1
(de)
*
|
1990-03-27 |
1994-12-15 |
Bioelastics Res Ltd |
Bioelastomeres arzneimittelabgabesystem.
|
|
JPH07108232B2
(ja)
|
1990-10-09 |
1995-11-22 |
エム・ディ・リサーチ株式会社 |
ペプチド又は蛋白質の製造方法
|
|
US5235041A
(en)
*
|
1990-12-28 |
1993-08-10 |
Protein Polymer Technologies, Inc. |
Purification of structurally ordered recombinant protein polymers
|
|
US5646016A
(en)
*
|
1991-02-06 |
1997-07-08 |
Genetics Institute, Inc. |
Peptide and protein fusions to thioredoxin, thioredoxin-like molecules, and modified thioredoxin-like molecules
|
|
US5595732A
(en)
|
1991-03-25 |
1997-01-21 |
Hoffmann-La Roche Inc. |
Polyethylene-protein conjugates
|
|
US5393602A
(en)
|
1991-04-19 |
1995-02-28 |
Bioelastics Research Ltd. |
Superabsorbent materials and uses thereof
|
|
US5958881A
(en)
|
1991-04-25 |
1999-09-28 |
Korman; Louis Y. |
Composition containing VIP for injection and a method of enhancing visualization of tissues during medical procedures
|
|
IL99924A
(en)
|
1991-10-31 |
1995-12-31 |
Yeda Res & Dev |
Derivatives of structurally modified vip and pharmaceutical compositions containing them
|
|
US5681816A
(en)
|
1992-04-24 |
1997-10-28 |
Korman; Louis Y. |
Method of inducing temporary paralysis of the gastrointestinal tract during medical procedure
|
|
EP0969016A2
(en)
|
1992-06-15 |
2000-01-05 |
Scios Inc. |
Glucagon-like peptide and insulinotropin derivates
|
|
US5288514A
(en)
|
1992-09-14 |
1994-02-22 |
The Regents Of The University Of California |
Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
|
|
US5972883A
(en)
|
1993-03-16 |
1999-10-26 |
Yeda Research And Development Co. Ltd. |
Method for the treatment of neurodegenerative diseases by administering VIP, an analogue, fragment or a conjugate thereof
|
|
DK38293D0
(da)
|
1993-03-31 |
1993-03-31 |
Novo Nordisk As |
Fremstilling af proteiner
|
|
US5545617A
(en)
|
1993-11-12 |
1996-08-13 |
The Schepens Eye Research Institute, Inc. |
Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion
|
|
US5705483A
(en)
*
|
1993-12-09 |
1998-01-06 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptides, compositions and methods
|
|
CA2137206A1
(en)
|
1993-12-09 |
1995-06-10 |
John A. Galloway |
Glucagon-like insulinotropic peptides, compositions and methods
|
|
US5900405A
(en)
*
|
1994-01-24 |
1999-05-04 |
Bioelastics Research, Ltd. |
Polymers responsive to electrical energy
|
|
JPH10502333A
(ja)
|
1994-04-07 |
1998-03-03 |
プロティーンニックス カンパニー |
バソアクティブ・インテスティナル・ポリペプチド
|
|
US5527610A
(en)
*
|
1994-05-20 |
1996-06-18 |
The Uab Research Foundation |
Elastomeric polypeptide matrices for preventing adhesion of biological materials
|
|
CA2196788A1
(en)
|
1994-08-09 |
1996-02-22 |
Mohamed E. El Halawani |
Dna encoding turkey hypothalamic vasoactive intestinal peptide
|
|
US6004782A
(en)
*
|
1995-04-14 |
1999-12-21 |
Bioelastics Research Ltd. |
Hyperexpression of bioelastic polypeptides
|
|
US5854387A
(en)
|
1995-04-14 |
1998-12-29 |
Bioelastics Research, Ltd. |
Simple method for the purification of a bioelastic polymer
|
|
US5972406A
(en)
*
|
1995-04-14 |
1999-10-26 |
Bioelastics Research Ltd. |
Bioelastomers suitable as food product additives
|
|
US5624711A
(en)
|
1995-04-27 |
1997-04-29 |
Affymax Technologies, N.V. |
Derivatization of solid supports and methods for oligomer synthesis
|
|
US6037321A
(en)
|
1995-05-03 |
2000-03-14 |
Biostar Inc. |
Fusion proteins comprising vasoactive intestinal peptide or PACAP
|
|
US5998588A
(en)
*
|
1995-09-01 |
1999-12-07 |
University Of Washington |
Interactive molecular conjugates
|
|
DK0851925T3
(da)
|
1995-09-21 |
2005-11-28 |
Genentech Inc |
Humane Væksthormonvarianter
|
|
US5702717A
(en)
*
|
1995-10-25 |
1997-12-30 |
Macromed, Inc. |
Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
|
|
MX336813B
(es)
|
1996-02-09 |
2016-02-02 |
Abbvie Biotechnology Ltd |
Anticuerpos humanos que ligan el tnfa humano.
|
|
US6063061A
(en)
|
1996-08-27 |
2000-05-16 |
Fusion Medical Technologies, Inc. |
Fragmented polymeric compositions and methods for their use
|
|
IL128332A0
(en)
|
1996-08-30 |
2000-01-31 |
Novo Nordisk As |
GLP-1 derivatives
|
|
US5816259A
(en)
|
1997-01-13 |
1998-10-06 |
Rose; Samuel |
Method for the diagnosis and treatment of cancer by the accumulation of radioactive precipitates in targeted cells
|
|
FI103540B
(fi)
|
1997-04-28 |
1999-07-15 |
Nokia Mobile Phones Ltd |
Menetelmä pakettikytkentäisen datan siirtoon matkapuhelinjärjestelmäss ä
|
|
GB9718463D0
(en)
|
1997-08-29 |
1997-11-05 |
Dynal As |
Biomolecules
|
|
US20020099003A1
(en)
|
1997-10-28 |
2002-07-25 |
Wilson Leland F. |
Treatment of female sexual dysfunction with vasoactive agents, particularly vasoactive intestinal polypeptide and agonists thereof
|
|
EP0978565B1
(en)
|
1998-01-30 |
2007-10-10 |
Asubio Pharma Co., Ltd. |
Process for producing peptide with the use of accessory peptide
|
|
US6703359B1
(en)
*
|
1998-02-13 |
2004-03-09 |
Amylin Pharmaceuticals, Inc. |
Inotropic and diuretic effects of exendin and GLP-1
|
|
AU2798599A
(en)
*
|
1998-02-27 |
1999-09-15 |
Bioelastics Research Ltd. |
Injectable implants for tissue augmentation and restoration
|
|
US6998387B1
(en)
*
|
1998-03-19 |
2006-02-14 |
Amylin Pharmaceuticals, Inc. |
Human appetite control by glucagon-like peptide receptor binding compounds
|
|
FR2776520B1
(fr)
|
1998-03-25 |
2000-05-05 |
Sod Conseils Rech Applic |
Nouvelles compositions pharmaceutiques destinees a la liberation prolongee de peptides et leur procede de preparation
|
|
US20020151458A1
(en)
|
1998-04-17 |
2002-10-17 |
Perez Gomariz Rosa Maria |
Method for treating and preventing septic shock with VPAC1R, VPAC2R and PAC1R agonists
|
|
US6153655A
(en)
|
1998-04-17 |
2000-11-28 |
Enzon, Inc. |
Terminally-branched polymeric linkers and polymeric conjugates containing the same
|
|
ES2138561B1
(es)
|
1998-04-17 |
2000-07-01 |
Univ Madrid Complutense |
Uso de los peptidos vip y pacap en el tratamiento del shock endotoxico en mamiferos.
|
|
US6200598B1
(en)
*
|
1998-06-18 |
2001-03-13 |
Duke University |
Temperature-sensitive liposomal formulation
|
|
US6451986B1
(en)
|
1998-06-22 |
2002-09-17 |
Immunex Corporation |
Site specific protein modification
|
|
US6541033B1
(en)
|
1998-06-30 |
2003-04-01 |
Amgen Inc. |
Thermosensitive biodegradable hydrogels for sustained delivery of leptin
|
|
US6406921B1
(en)
|
1998-07-14 |
2002-06-18 |
Zyomyx, Incorporated |
Protein arrays for high-throughput screening
|
|
DE69941510D1
(de)
|
1998-08-10 |
2009-11-19 |
Us Gov Nat Inst Health |
Differenzierung von nicht-insulin in insulin-produzierende zellen durch glp-1 und exendin-4 und dessen verwendung
|
|
CZ295044B6
(cs)
|
1998-12-07 |
2005-05-18 |
Societe De Conseils De Recherches Et D'application |
Analogy GLP-1, mající kyselinu aminoizomáselnou na pozicích 8 a 35, jejich použití a farmaceutické prostředky je obsahující
|
|
US6630438B1
(en)
|
1999-03-12 |
2003-10-07 |
The Procter & Gamble Company |
Perfumed detergent tablet
|
|
AU3867400A
(en)
|
1999-03-19 |
2000-10-09 |
Duke University |
Methods of using bioelastomers
|
|
BR0010750A
(pt)
|
1999-05-17 |
2002-02-26 |
Conjuchem Inc |
Peptìdeos insulinotrópicos de longa duração
|
|
US20090175821A1
(en)
|
1999-05-17 |
2009-07-09 |
Bridon Dominique P |
Modified therapeutic peptides with extended half-lives in vivo
|
|
CZ299516B6
(cs)
|
1999-07-02 |
2008-08-20 |
F. Hoffmann-La Roche Ag |
Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
|
|
US6528486B1
(en)
*
|
1999-07-12 |
2003-03-04 |
Zealand Pharma A/S |
Peptide agonists of GLP-1 activity
|
|
EP1076066A1
(en)
|
1999-07-12 |
2001-02-14 |
Zealand Pharmaceuticals A/S |
Peptides for lowering blood glucose levels
|
|
EP1233811A2
(en)
|
1999-11-12 |
2002-08-28 |
Leo Rubin |
Methods for treating cardiac arrest or pulmonary hypertension and compositions for use therein comprising vasoactive intestinal polypeptide and cardiac device for electrical and chemical regulation and methods of use
|
|
US6235264B1
(en)
|
1999-12-01 |
2001-05-22 |
General Electric Company |
Medical imaging method for characterizing tumor angiogenesis using polymeric contrast agents
|
|
US6593394B1
(en)
|
2000-01-03 |
2003-07-15 |
Prosperous Kingdom Limited |
Bioactive and osteoporotic bone cement
|
|
US7833992B2
(en)
|
2001-05-18 |
2010-11-16 |
Merck Sharpe & Dohme |
Conjugates and compositions for cellular delivery
|
|
US6489297B1
(en)
|
2000-02-18 |
2002-12-03 |
Dabur Research Foundation |
Vasoactive intestinal peptide analogs
|
|
US6852834B2
(en)
*
|
2000-03-20 |
2005-02-08 |
Ashutosh Chilkoti |
Fusion peptides isolatable by phase transition
|
|
US20050255554A1
(en)
*
|
2000-03-20 |
2005-11-17 |
Ashutosh Chilkoti |
Fusion peptides isolatable by phase transition
|
|
EP2213743A1
(en)
|
2000-04-12 |
2010-08-04 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
US6905683B2
(en)
|
2000-05-03 |
2005-06-14 |
Novo Nordisk Healthcare A/G |
Human coagulation factor VII variants
|
|
JP4716641B2
(ja)
*
|
2000-06-16 |
2011-07-06 |
イーライ リリー アンド カンパニー |
グルカゴン様ペプチド−１類似体
|
|
US20030211094A1
(en)
|
2001-06-26 |
2003-11-13 |
Nelsestuen Gary L. |
High molecular weight derivatives of vitamin k-dependent polypeptides
|
|
MXPA03001984A
(es)
|
2000-09-13 |
2003-08-29 |
Novo Nordisk Healthcare Ag |
Variantes de factor vii de coagulacion humano.
|
|
US20020142964A1
(en)
|
2000-11-02 |
2002-10-03 |
Nissen Torben Lauesgaard |
Single-chain polypeptides
|
|
AU2072002A
(en)
|
2000-11-28 |
2002-06-11 |
Mondobiotech Sa |
Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension
|
|
IL155812A0
(en)
|
2000-12-07 |
2003-12-23 |
Lilly Co Eli |
Glp-1 fusion proteins
|
|
AU3938402A
(en)
*
|
2000-12-13 |
2002-06-24 |
Lilly Co Eli |
Chronic treatment regimen using glucagon-like insulinotropic peptides
|
|
DK1360202T3
(da)
|
2001-02-16 |
2008-09-22 |
Conjuchem Biotechnologies Inc |
Langvarigt glucagon-lignende peptid 2 (GLP-2) til behandling af gastrointestinale sygdomme og lidelser
|
|
US7235638B2
(en)
|
2001-03-22 |
2007-06-26 |
Novo Nordisk Healthcare A/G |
Coagulation factor VII derivatives
|
|
CZ20032454A3
(en)
|
2001-03-22 |
2004-03-17 |
Novo Nordisk Health Care Ag |
Coagulation factor vii derivative
|
|
AU2002308706A1
(en)
*
|
2001-06-01 |
2002-12-16 |
Eli Lilly And Company |
Glp-1 formulations with protracted time action
|
|
AU2002322403A1
(en)
*
|
2001-08-23 |
2003-03-10 |
Eli Lilly And Company |
Glucagon-like peptide-1 analogs
|
|
EP1432430A4
(en)
*
|
2001-08-28 |
2006-05-10 |
Lilly Co Eli |
PREMIXTURES OF GLP-1 AND BASALINSULIN
|
|
US7176278B2
(en)
|
2001-08-30 |
2007-02-13 |
Biorexis Technology, Inc. |
Modified transferrin fusion proteins
|
|
MXPA04003569A
(es)
*
|
2001-10-19 |
2004-07-23 |
Lilly Co Eli |
Mezclas bifasicas de glp-1 e insulina.
|
|
JP4249025B2
(ja)
|
2001-11-06 |
2009-04-02 |
千寿製薬株式会社 |
ドライアイおよびドライアイを伴う疾病の治療剤
|
|
DE10155862A1
(de)
|
2001-11-14 |
2003-05-28 |
Ipk Inst Fuer Pflanzengenetik |
Produktion von rekombinanten Antikörpern mittels Fusion mit Elastin-ähnlichen Peptiden
|
|
AU2002364586A1
(en)
|
2001-12-21 |
2003-07-30 |
Delta Biotechnology Limited |
Albumin fusion proteins
|
|
US7553485B2
(en)
|
2002-01-18 |
2009-06-30 |
Pierre Fabre Medicament |
Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof
|
|
US20030199445A1
(en)
|
2002-02-07 |
2003-10-23 |
Knudsen Lotte Bjerre |
Use of GLP-1 compound for treatment of critically ill patients
|
|
AU2003241531A1
(en)
|
2002-05-21 |
2003-12-12 |
Emory University |
Multivalent polymers with chain-terminating binding groups
|
|
AU2003236072B2
(en)
|
2002-06-10 |
2008-10-23 |
Mondobiotech Ag |
Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis
|
|
US20060130158A1
(en)
|
2002-08-30 |
2006-06-15 |
Turner Andrew J |
Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains
|
|
EP1571155B1
(en)
|
2002-11-27 |
2011-08-24 |
Ils Inc. |
Peptides and medicinal compositions containing the same
|
|
US20050026826A1
(en)
*
|
2003-01-17 |
2005-02-03 |
Margarethe Hoenig |
Feline proinsulin, insulin and constituent peptides
|
|
EP1633382A4
(en)
|
2003-05-14 |
2009-08-05 |
Dow Corning |
REPEAT SEQUENCE PROTEIN-POLYMER-ACTIVE CONJUGATE, METHOD AND USES
|
|
PL1633391T3
(pl)
*
|
2003-06-03 |
2012-03-30 |
Novo Nordisk As |
Stabilizowane farmaceutycznie kompozycje peptydowe
|
|
DK1641823T3
(da)
|
2003-06-12 |
2011-12-12 |
Lilly Co Eli |
GLP-1-analog fusionsproteiner
|
|
US20040266993A1
(en)
*
|
2003-06-30 |
2004-12-30 |
Evans Glen A. |
Non-immunoglobulin binding polypeptides
|
|
AU2004255379B2
(en)
|
2003-07-14 |
2007-08-16 |
Mondobiotech Ag |
Biologically active substance of a vasoactive intestinal peptide for treating interstitial lung infections
|
|
WO2005014030A1
(en)
|
2003-07-24 |
2005-02-17 |
Lutz-Henning Block |
Method for treating lung diseases associated with ventilation-perfusion mismatches
|
|
BRPI0507156A
(pt)
|
2004-02-05 |
2007-06-26 |
Novo Nordisk Healthcare Ag |
uso de fator viia ou de um equivalente de fator viia, kit de partes e método para prevenir ou atenuar uma ou mais complicações tardias de trauma, e, métodos para reduzir o número de dias em que um paciente de trauma é hospitalizado após trauma, para reduzir o número de dias que um paciente de trauma passa em uma unidade de tratamento intensivo após trauma, para melhorar função pulmonar em um paciente de trauma, para reduzir o risco de desenvolver lesão pulmonar aguda e/ou sìndrome do sofrimento respiratório agudo em um paciente de trauma, para reduzir o risco de desenvolver coagulação intravascular disseminada em um paciente de trauma, para reduzir o risco de desenvolver sìndrome da resposta inflamatória sistêmica em um paciente de trauma, para reduzir o risco de desenvolver falha de órgãos múltiplos em um paciente de trauma, para reduzir o risco de morte em um paciente de trauma e para prevenir ou atenuar uma ou mais complicações tardias de trauma
|
|
US7776815B2
(en)
|
2004-02-24 |
2010-08-17 |
Wisconsin Alumni Research Foundation |
Use of neuropeptides for ligament healing
|
|
US7928059B2
(en)
|
2004-02-24 |
2011-04-19 |
Wisconsin Alumni Research Foundation |
Use of neuropeptides for traumatic cartilage injury
|
|
US20050203009A1
(en)
|
2004-03-12 |
2005-09-15 |
Bayer Pharmaceuticals Corporation |
VPAC1 selective antagonists and their pharmacological methods of use
|
|
WO2005097158A1
(en)
|
2004-03-29 |
2005-10-20 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Amphipathic glycopeptides
|
|
ES2523659T3
(es)
|
2004-06-11 |
2014-11-28 |
Vectus Biosystems Limited |
Composiciones y procedimientos para el tratamiento de enfermedades cardiovasculares
|
|
CA2575101A1
(en)
|
2004-06-12 |
2005-12-29 |
Bayer Pharmaceuticals Corporation |
Pegylation of vasoactive intestinal peptide (vip)/pituitary adenylate cyclase activating peptide (pacap) receptor 2 (vpac2) agonists and methods of use
|
|
WO2006001806A2
(en)
|
2004-06-15 |
2006-01-05 |
Duke University |
Method for non-invasive thermometry using elastin-like polypeptide conjugates
|
|
WO2006091231A2
(en)
*
|
2004-07-21 |
2006-08-31 |
Ambrx, Inc. |
Biosynthetic polypeptides utilizing non-naturally encoded amino acids
|
|
US20080085860A1
(en)
|
2004-08-18 |
2008-04-10 |
Eli Lilly And Company |
Selective Vpac2 Receptor Peptide Agonists
|
|
BRPI0516126A
(pt)
|
2004-10-08 |
2008-08-26 |
Forbes Medi Tech Res Inc |
produtos farmacêuticos de polipeptìdeos intestinais vasoativos
|
|
SE0402976L
(sv)
*
|
2004-12-03 |
2006-06-04 |
Mederio Ag |
Medicinsk produkt
|
|
KR20070095927A
(ko)
|
2004-12-03 |
2007-10-01 |
메데리오 에이지 |
폐 흡입을 위한 글루카곤-형 펩타이드 약제를 포함하는의약품
|
|
WO2006078629A2
(en)
|
2005-01-18 |
2006-07-27 |
Duke University |
In-situ crosslinkable elastin-like polypeptides for defect filling in cartilaginous tissue repair
|
|
US7723472B2
(en)
|
2005-02-28 |
2010-05-25 |
The Regents Of The University Of California |
Extracellular matrix binding chimeric proteins and methods of use thereof
|
|
WO2006110292A2
(en)
|
2005-03-25 |
2006-10-19 |
The Regents Of The University Of California |
Temperature-triggered immobilization and purification of antibodies
|
|
EP1889618A4
(en)
|
2005-05-27 |
2010-11-24 |
Daiichi Sankyo Co Ltd |
Combined drug for treating diabetes
|
|
US20070031342A1
(en)
|
2005-06-22 |
2007-02-08 |
Nektar Therapeutics |
Sustained release microparticles for pulmonary delivery
|
|
EP2664340B1
(en)
|
2005-06-24 |
2020-02-12 |
Duke University |
A direct drug delivery system based on thermally responsive biopolymers
|
|
US20070041934A1
(en)
|
2005-08-12 |
2007-02-22 |
Regents Of The University Of Michigan |
Dendrimer based compositions and methods of using the same
|
|
US7542904B2
(en)
*
|
2005-08-19 |
2009-06-02 |
Cisco Technology, Inc. |
System and method for maintaining a speech-recognition grammar
|
|
DE602005017628D1
(de)
*
|
2005-09-22 |
2009-12-24 |
Biocompatibles Uk Ltd |
Fusionspolypeptide vom glp-1 (glucagon-like peptide-1) mit erhöhten peptidaseresistenz
|
|
CN101296708B
(zh)
|
2005-10-26 |
2011-12-07 |
伊莱利利公司 |
选择性vpac2受体肽激动剂
|
|
ATE458000T1
(de)
|
2005-11-18 |
2010-03-15 |
Dabur Pharma Ltd |
Zielgerichtete fusionsproteine für die krebstherapie
|
|
NZ623674A
(en)
|
2005-12-09 |
2014-07-25 |
Vectus Biosystems Ltd |
Vip fragments and methods of use
|
|
US20130172274A1
(en)
|
2005-12-20 |
2013-07-04 |
Duke University |
Methods and compositions for delivering active agents with enhanced pharmacological properties
|
|
WO2007073486A2
(en)
*
|
2005-12-20 |
2007-06-28 |
Duke University |
Methods and compositions for delivering active agents with enhanced pharmacological properties
|
|
US8841255B2
(en)
|
2005-12-20 |
2014-09-23 |
Duke University |
Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
|
|
US7709227B2
(en)
|
2006-01-04 |
2010-05-04 |
Phasebio Pharmaceuticals, Inc. |
Multimeric ELP fusion constructs
|
|
CA2638800A1
(en)
*
|
2006-02-22 |
2007-09-07 |
Merck & Co., Inc. |
Oxyntomodulin derivatives
|
|
AU2007223855B2
(en)
|
2006-03-06 |
2013-05-16 |
Amunix Operating Inc. |
Unstructured recombinant polymers and uses thereof
|
|
ES2315081B1
(es)
|
2006-03-15 |
2009-12-30 |
Grup D'afectats D'esclerosi Multiple (Gaem) |
Nuevo uso del peptido intestinal vasoactivo (vip) y de las celulas aisladas estimuladas con dicho peptido.
|
|
EP2043689A4
(en)
|
2006-07-24 |
2013-08-07 |
Univ Duke |
ACTIVE ADMINISTRATION WITH STIMULUS-REPONSIVE BIOPOLYMERS
|
|
US9505823B2
(en)
|
2006-08-07 |
2016-11-29 |
TEV A Biopharmaceuticals USA, Inc. |
Albumin-insulin fusion proteins
|
|
JP5290177B2
(ja)
*
|
2006-08-31 |
2013-09-18 |
セントカー・インコーポレーテツド |
Ｇｌｐ−２ミメティボディ、ポリペプチド、組成物、方法および用途
|
|
CA2663047A1
(en)
|
2006-09-06 |
2008-03-13 |
Phase Bioscience, Inc. |
Therapeutic elastin-like polypeptide (elp) fusion proteins
|
|
EP2152741B1
(en)
|
2007-05-21 |
2011-09-21 |
Res International Sarl |
Peptides with improved properties having the biological activity of vasoactive intestinal peptide (vip) and their use for the treatment of lung diseases
|
|
PL2155169T3
(pl)
|
2007-06-08 |
2016-09-30 |
|
Formulacja newirapiny o przedłużonym uwalnianiu
|
|
SI2173890T1
(sl)
|
2007-06-21 |
2011-06-30 |
Univ Muenchen Tech |
Biološko aktivni proteini, ki imajo povečano in vivo in/ali in vitro stabilnost
|
|
JP2010536341A
(ja)
*
|
2007-08-15 |
2010-12-02 |
アムニクス， インコーポレイテッド |
生物学的に活性なポリペプチドの特性を改変するための組成物および方法
|
|
EP2190872B1
(en)
|
2007-09-05 |
2018-03-14 |
Novo Nordisk A/S |
Glucagon-like peptide-1 derivatives and their pharmaceutical use
|
|
JP2011503000A
(ja)
|
2007-11-02 |
2011-01-27 |
セントコア・オーソ・バイオテツク・インコーポレーテツド |
半合成ＧＬＰ−１ペプチド−Ｆｃ融合コンストラクト、その方法及び使用
|
|
US20110207673A1
(en)
|
2007-11-20 |
2011-08-25 |
Ashutosh Chilkoti |
Methods and compositions for modulating drug-polymer architecture, pharmacokinetics and biodistribution
|
|
CN102131516B
(zh)
|
2008-06-27 |
2016-03-16 |
杜克大学 |
包含弹性蛋白样肽的治疗剂
|
|
ES2603963T3
(es)
|
2008-10-17 |
2017-03-02 |
Vectus Biosystems Limited |
Composiciones y métodos para el tratamiento de trastornos renales
|
|
US20110288001A1
(en)
|
2008-12-18 |
2011-11-24 |
Homayoun Sadeghi |
Biologically active proteins activatable by peptidase
|
|
US8703717B2
(en)
|
2009-02-03 |
2014-04-22 |
Amunix Operating Inc. |
Growth hormone polypeptides and methods of making and using same
|
|
US9029505B2
(en)
|
2009-08-14 |
2015-05-12 |
Phasebio Pharmaceuticals, Inc. |
Modified vasoactive intestinal peptides
|
|
TW201138808A
(en)
*
|
2010-05-03 |
2011-11-16 |
Bristol Myers Squibb Co |
Serum albumin binding molecules
|
|
CA2873553C
(en)
|
2011-06-06 |
2020-01-28 |
Phasebio Pharmaceuticals, Inc. |
Use of modified vasoactive intestinal peptides in the treatment of hypertension
|
|
CN104023784B
(zh)
|
2011-08-24 |
2018-05-25 |
费斯生物制药公司 |
供持续释放的活性剂制剂
|
|
JP2014534265A
(ja)
|
2011-11-28 |
2014-12-18 |
フェーズバイオ ファーマシューティカルズ，インコーポレイテッド |
インスリンアミノ酸配列を含む治療薬
|
|
US9605186B2
(en)
|
2012-09-19 |
2017-03-28 |
Exxonmobil Chemical Patents Inc. |
Adhesive compositions of ethylene-based and propylene-based polymers
|